Therapeutic implications of C. albicans-S. aureus mixed biofilm in a murine subcutaneous catheter model of polymicrobial infection
Open Access
- 8 March 2021
- journal article
- research article
- Published by Taylor & Francis in Virulence
- Vol. 12 (1) , 835-851
Abstract
Biofilm-associated polymicrobial infections tend to be challenging to treat. Candida albicans and Staphylococcus aureus are leading pathogens due to their ability to form biofilms on medical devices. However, the therapeutic implications of their interactions in a host is largely unexplored. In this study, we used a mouse subcutaneous catheter model for in vivo-grown polymicrobial biofilms to validate our in vitro findings on C. albicans-mediated enhanced S. aureus tolerance to vancomycin in vivo. Comparative assessment of S. aureus recovery from catheters with single- or mixed-species infection demonstrated failure of vancomycin against S. aureus in mice with co-infected catheters. To provide some mechanistic insights, RNA-seq analysis was performed on catheter biofilms to delineate transcriptional modulations during polymicrobial infections. C. albicans induced the activation of the S. aureus biofilm formation network via down-regulation of the lrg operon, repressor of autolysis, and up-regulation of the ica operon and production of polysaccharide intercellular adhesin (PIA), indicating an increase in eDNA production, and extracellular polysaccharide matrix, respectively. Interestingly, virulence factors important for disseminated infections, and superantigen-like proteins were down-regulated during mixed-species infection, whereas capsular polysaccharide genes were up-regulated, signifying a strategy favoring survival, persistence and host immune evasion. In vitro follow-up experiments using DNA enzymatic digestion, lrg operon mutant strains, and confocal scanning microscopy confirmed the role of C. albicans-mediated enhanced eDNA production in mixed-biofilms on S. aureus tolerance to vancomycin. Combined, these findings provide mechanistic insights into the therapeutic implications of interspecies interactions, underscoring the need for novel strategies to overcome limitations of current therapies.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health (R01AI130170)
- National Institutes of Health (U19AI110820)
This publication has 72 references indexed in Scilit:
- Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3pMicrobiology, 2012
- Polymicrobial Interactions: Impact on Pathogenesis and Human DiseaseClinical Microbiology Reviews, 2012
- Interface of Candida albicans Biofilm Matrix-Associated Drug Resistance and Cell Wall Integrity RegulationEukaryotic Cell, 2011
- Importance of Candida–bacterial polymicrobial biofilms in diseaseTrends in Microbiology, 2011
- In Vivo Efficacy of Anidulafungin against Mature Candida albicans Biofilms in a Novel Rat Model of Catheter-Associated CandidiasisAntimicrobial Agents and Chemotherapy, 2010
- Ability of Candida albicans Mutants To Induce Staphylococcus aureus Vancomycin Resistance during Polymicrobial Biofilm FormationAntimicrobial Agents and Chemotherapy, 2010
- Microbial interactions and differential protein expression inStaphylococcus aureus–Candida albicansdual-species biofilmsFEMS Immunology & Medical Microbiology, 2010
- Genetic Basis ofCandidaBiofilm Resistance Due to Drug‐Sequestering Matrix GlucanThe Journal of Infectious Diseases, 2010
- Candida albicans and Staphylococcus aureus Form Polymicrobial Biofilms: Effects on Antimicrobial ResistanceAntimicrobial Agents and Chemotherapy, 2009
- Fluorescence Ratio Imaging Microscopy Shows Decreased Access of Vancomycin to Cell Wall Synthetic Sites in Vancomycin-ResistantStaphylococcus aureusAntimicrobial Agents and Chemotherapy, 2007